Guest guest Posted March 6, 2011 Report Share Posted March 6, 2011 New Treatments For Liver Cancer KSAT San They also have the added bonus of being 10-times more aggressive against the hepatitis C virus. s Tzakis, MD, Professor of Surgery, Director of Liver and Gastrointestinal Transplant Program at U of Miami/ Memorial Hospital., tells us about ... See all stories on this topic » Phase 2 Trial Shows Telaprevir Lowers Hepatitis C Viral Levels In People With .... The AIDS Beacon Interim results from a Phase 2 trial showed that the investigational drug telaprevir lowers hepatitis C viral levels in people infected with both HIV and hepatitis C. Results also showed that telaprevir is well tolerated and safe to use, causing mild ... See all stories on this topic » IL28B Genotype Predicts Treatment Response in Chronic Hepatitis C Internal Medicine News Digital Network Patients with treatment-naive chronic hepatitis C virus infection who carry the rs12979860 C/C or rs8099917 T/T polymorphisms in the region of the IL28B gene are more likely than are noncarriers to show an early virologic response, ... See all stories on this topic » CROI: HCV Drug Seems Safe in HIV Coinfected Patients MedPage Today Explain that early results showed telaprevir decreased detectable hepatitis C virus in patients coinfected with HIV without an apparent increase in antiretroviral drug interactions or adverse events. Note that the study population is small and the ... See all stories on this topic » Extra support on the way for victims of tainted blood Aberdeen Press and Journal By Tim ing More people who were infected with potentially fatal hepatitis C while being treated with contaminated NHS blood or blood products will be eligible for additional support. While the extra money for sufferers and bereaved relatives was ... See all stories on this topic » Quote Link to comment Share on other sites More sharing options...
Guest guest Posted March 6, 2011 Report Share Posted March 6, 2011 New Treatments For Liver Cancer KSAT San They also have the added bonus of being 10-times more aggressive against the hepatitis C virus. s Tzakis, MD, Professor of Surgery, Director of Liver and Gastrointestinal Transplant Program at U of Miami/ Memorial Hospital., tells us about ... See all stories on this topic » Phase 2 Trial Shows Telaprevir Lowers Hepatitis C Viral Levels In People With .... The AIDS Beacon Interim results from a Phase 2 trial showed that the investigational drug telaprevir lowers hepatitis C viral levels in people infected with both HIV and hepatitis C. Results also showed that telaprevir is well tolerated and safe to use, causing mild ... See all stories on this topic » IL28B Genotype Predicts Treatment Response in Chronic Hepatitis C Internal Medicine News Digital Network Patients with treatment-naive chronic hepatitis C virus infection who carry the rs12979860 C/C or rs8099917 T/T polymorphisms in the region of the IL28B gene are more likely than are noncarriers to show an early virologic response, ... See all stories on this topic » CROI: HCV Drug Seems Safe in HIV Coinfected Patients MedPage Today Explain that early results showed telaprevir decreased detectable hepatitis C virus in patients coinfected with HIV without an apparent increase in antiretroviral drug interactions or adverse events. Note that the study population is small and the ... See all stories on this topic » Extra support on the way for victims of tainted blood Aberdeen Press and Journal By Tim ing More people who were infected with potentially fatal hepatitis C while being treated with contaminated NHS blood or blood products will be eligible for additional support. While the extra money for sufferers and bereaved relatives was ... See all stories on this topic » Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.